Companies / ARS Pharmaceuticals, Inc. / Activity
Activity — ARS Pharmaceuticals, Inc.
14 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Fitzpatrick Alexander A Executive | Sell | Common Stock | $33.5K | -3K -3.56% | 90,910 0.09% of shares | low |
| Jun 24, 2026 | Thompson Peter A. Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 24, 2026 | RA Capital Management, L.P. Director | Grant | Stock Option (Right to Buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 24, 2026 | Saunders Brent L Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 24, 2026 | Schneider Phillip M Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jan 2, 2026 | Scott Kathleen D. Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Tanimoto Sarina Executive | Grant | Stock Option (right to buy) | — | +875K | 875,000 0.88% of shares | low |
| Jan 2, 2026 | Tanimoto Sarina Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Karas Eric Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Chakma Justin Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Fitzpatrick Alexander A Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Dorsey Brian Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Lowenthal Richard E CEO | Grant | Stock Option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Lowenthal Richard E CEO | Grant | Stock option (right to buy) | — | +875K | 875,000 0.88% of shares | low |